Peng, S.-W.; Ngo, M.-H.T.; Kuo, Y.-C.; Teng, M.-H.; Guo, C.-L.; Lai, H.-C.; Chang, T.-S.; Huang, Y.-H.
Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma. Cancers 2023, 15, 931.
https://doi.org/10.3390/cancers15030931
AMA Style
Peng S-W, Ngo M-HT, Kuo Y-C, Teng M-H, Guo C-L, Lai H-C, Chang T-S, Huang Y-H.
Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma. Cancers. 2023; 15(3):931.
https://doi.org/10.3390/cancers15030931
Chicago/Turabian Style
Peng, Syue-Wei, Mai-Huong T. Ngo, Yung-Che Kuo, Ming-Hao Teng, Chin-Lin Guo, Hung-Cheng Lai, Te-Sheng Chang, and Yen-Hua Huang.
2023. "Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma" Cancers 15, no. 3: 931.
https://doi.org/10.3390/cancers15030931
APA Style
Peng, S.-W., Ngo, M.-H. T., Kuo, Y.-C., Teng, M.-H., Guo, C.-L., Lai, H.-C., Chang, T.-S., & Huang, Y.-H.
(2023). Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma. Cancers, 15(3), 931.
https://doi.org/10.3390/cancers15030931